SuperSmart← Back to DiscoverDiscover
RESEARCH DRAFT

Research draft. Conclusions may change; review the sources and limitations before relying on them.

RESEARCH DRAFT · NOT A VERIFIED CONCLUSION

J&J reversed roughly $7 billion after its talc bankruptcy plan failed. That did not make the claims disappear.

A rejected settlement route produced an accounting reversal—not a courtroom victory on every claim. A later proposal carried a new $5.5 billion commitment.

research_draftUpdated 2026-09-100 recorded actions
Conceptual generated illustration of documents and civic architectureCONCEPTUAL ILLUSTRATION

Monitor this connection

Sign in to your account to monitor updates
3Recorded evidence rows
0Investigation actions
4Review limitations
0Recorded answers

What this page shows

J&J's first-quarter 2025 filing reports that dismissal of the Red River Talc bankruptcy led it to reverse approximately $7 billion previously reserved for that resolution. The filing also says the litigation stay dissolved. Releasing a reserve changes accounting; it is not cash received from claimants or proof that all underlying claims failed. On July 27, 2026, J&J announced a different proposed resolution: a $5.5 billion commitment, conditional on participation by at least 95% of remaining claims and other requirements. The first payment would be no more than $3 billion in 2027, with no additional payments before 2028. J&J disputes the claims and points to favorable litigation developments. The connection to watch is the difference between a reserve reversal, an agreement meeting its participation conditions, and actual payments. Those are three different milestones.

Recorded evidence

SEC / J&J
First-quarter 2025 Form 10-Q: talc reserve reversal and dissolution of stayQuarter ended 2025-03-30
↗
J&J
Proposed ovarian talc resolution: participation conditions and payment schedule2026-07-27
↗
SEC / J&J
Form 8-K reporting the new conditional $5.5 billion commitment2026-07-27
↗

Limitations & review notes

  • Research draft. Conclusions may change; review the sources and limitations before relying on them.
  • Company filings and statements document its accounting and proposed terms; they are not independent adjudications of every underlying allegation.
  • The 2025 reserve and 2026 proposal have different scopes and timing. Subtracting them does not establish savings or compensation denied to claimants.
  • The July 2026 agreement was conditional when announced; this page does not establish that its conditions have since been satisfied.

Questions this connection opens

  1. What has Johnson & Johnson disclosed about talc settlement participation, reserves and payments since July 27, 2026?
  2. Which talc liabilities and legal costs remain outside the proposed ovarian-claim resolution?
Go deeper

Ask a follow-up question, compare another company, or review the supporting evidence.

Ask a follow-up